公开(公告)号：US20100016400A1

公开(公告)日：2010-01-21

申请号：US11719687

申请日：2005-11-18

Applicant: Naresh Kumar ,  Mohammad Salman ,  Kirandeep Kaur ,  Anita Mehta ,  Sudershan K. Arora ,  Anita Chugh

Inventor： Naresh Kumar ,  Mohammad Salman ,  Kirandeep Kaur ,  Anita Mehta ,  Sudershan K. Arora ,  Anita Chugh

IPC: A61K31/403 ,  C07D209/52 ,  C07D409/06 ,  A61P11/00

CPC classification number: C07D209/52 ,  C07D409/06

Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful for treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing compounds described herein, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.

Abstract translation: 本发明一般涉及毒蕈碱受体拮抗剂，其可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。 本发明还涉及制备本文所述化合物的方法，含有所公开化合物的药物组合物，以及用于治疗通过毒蕈碱受体介导的疾病的方法。

公开(公告)号：US07625579B2

公开(公告)日：2009-12-01

申请号：US10257245

申请日：2001-04-10

Applicant: Roger Read ,  Naresh Kumar ,  Mark Wilcox ,  Hua Zhu ,  Hnas Griesser ,  Ben Muir ,  Helmut Thissen ,  Tim Hughes

Inventor： Roger Read ,  Naresh Kumar ,  Mark Wilcox ,  Hua Zhu ,  Hnas Griesser ,  Ben Muir ,  Helmut Thissen ,  Tim Hughes

IPC: A61F2/00 ,  A01N43/08

CPC classification number: D06M16/00 ,  A01N25/34 ,  A01N43/36 ,  A61K31/341 ,  A61L27/28 ,  A61L27/54 ,  A61L2300/404 ,  D06M13/228 ,  D06M13/364 ,  Y10T442/2525 ,  A01N2300/00

Abstract: The present invention provides a substrate having a plurality of immobilised furanone moieties associated with at least part of a surface of the substrate. The invention also relates to articles consisting of or comprising such a substrate.

Abstract translation: 本发明提供了一种具有多个固定的呋喃酮部分的基底，该部分与基底的至少部分表面缔合。 本发明还涉及由这种基材组成或包含这种基材的制品。

公开(公告)号：US20090233999A1

公开(公告)日：2009-09-17

申请号：US12266449

申请日：2008-11-06

Applicant: ANDREW HEATON ,  NARESH KUMAR ,  GRAHAM EDMUND KELLY ,  ALAN HUSBAND

Inventor： ANDREW HEATON ,  NARESH KUMAR ,  GRAHAM EDMUND KELLY ,  ALAN HUSBAND

IPC: A61K31/35 ,  A61P19/02

CPC classification number: C07D471/06 ,  A23L33/10 ,  A23L33/11 ,  A23V2002/00 ,  C07C45/46 ,  C07D311/26 ,  C07D311/36 ,  C07D311/38 ,  C07D311/58 ,  C07C49/84 ,  C07C49/83 ,  A23V2250/2116 ,  A23V2200/30

Abstract: Isoflavone compounds and analogues thereof, compositions containing same and therapeutic methods of treatment involving same are described.

Abstract translation: 描述异黄酮化合物及其类似物，含有其的组合物和涉及其的治疗方法。

公开(公告)号：US07488748B2

公开(公告)日：2009-02-10

申请号：US10543585

申请日：2003-01-23

Applicant: Anita Mehta ,  Arundutt V. Silamkoti ,  Naresh Kumar ,  Jang Bahadur Gupta

Inventor： Anita Mehta ,  Arundutt V. Silamkoti ,  Naresh Kumar ,  Jang Bahadur Gupta

IPC: A61K31/403 ,  C07D209/52

CPC classification number: C07D401/04 ,  C07D209/52 ,  C07D401/06 ,  C07D403/04 ,  C07D405/04 ,  C07D405/06 ,  C07D409/04

Abstract: This invention generally relates to derivatives of 3,6 disubstituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

Abstract translation: 本发明一般涉及3,6-二取代的氮杂双环己烷的衍生物。 本发明的化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。 本发明还涉及含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

公开(公告)号：US07486110B2

公开(公告)日：2009-02-03

申请号：US11234862

申请日：2005-09-23

Applicant: Naresh Kumar Bhatti ,  Sonia Singhal

Inventor： Naresh Kumar Bhatti ,  Sonia Singhal

IPC: H03K19/173

CPC classification number: H03K19/17728

Abstract: An improved LUT based multiplexer, including a first set of muxlets, each receiving a subset of input data lines at its inputs and one or more muxlet stages cascaded together to form a tree structure in which the roots are the first set of muxlets and the last stage of muxlet produces the final output.

Abstract translation: 一种改进的基于LUT的多路复用器，包括第一组多路复用器，每个在其输入端接收输入数据线的子集，以及一个或多个多路复用级级联在一起以形成树结构，其中根是第一组多路复用器，最后一个 muxlet阶段产生最终输出。

公开(公告)号：US07446123B2

公开(公告)日：2008-11-04

申请号：US10552455

申请日：2004-01-07

Applicant: Mohammad Salman ,  Anita Mehta ,  Pakala Kumara Savithru Sarma ,  Naresh Kumar ,  Sankaranarayanan Dharmarajan ,  Kirandeep Kaur ,  Anita Chugh

Inventor： Mohammad Salman ,  Anita Mehta ,  Pakala Kumara Savithru Sarma ,  Naresh Kumar ,  Sankaranarayanan Dharmarajan ,  Kirandeep Kaur ,  Anita Chugh

IPC: A61K31/40 ,  A61K31/4035 ,  C07D209/52

CPC classification number: C07D209/52 ,  C07D403/06

Abstract: This invention generally relates to muscarinic receptor antagonists of formula (I) which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

Abstract translation: 本发明一般涉及式（I）的毒蕈碱受体拮抗剂，其可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病的其它用途。 本发明还涉及含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

公开(公告)号：US20080255188A1

公开(公告)日：2008-10-16

申请号：US11995433

申请日：2006-07-11

Applicant: Naresh Kumar ,  Mohammad Salman ,  Kirandeep Kaur ,  Anita Chugh ,  Sandeep Sinha

Inventor： Naresh Kumar ,  Mohammad Salman ,  Kirandeep Kaur ,  Anita Chugh ,  Sandeep Sinha

IPC: A61K31/472 ,  C07D217/26

CPC classification number: C07D471/08

Abstract: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.

Abstract translation: 本发明一般涉及式（I）的毒蕈碱受体拮抗剂，其可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。 本发明还涉及制备所公开的化合物的方法，含有所公开的化合物的药物组合物，以及用于治疗通过毒蕈碱受体介导的疾病的方法。

公开(公告)号：US07366098B1

公开(公告)日：2008-04-29

申请号：US10222275

申请日：2002-08-15

Applicant: Raja Rangarjan ,  Ashish Gupta ,  Rohit Sharma ,  Naresh Kumar Sharma ,  Frederic Mathieu ,  Jayakumar Jayakumar

Inventor： Raja Rangarjan ,  Ashish Gupta ,  Rohit Sharma ,  Naresh Kumar Sharma ,  Frederic Mathieu ,  Jayakumar Jayakumar

IPC: H04L12/26 ,  H04J3/14 ,  G08C15/00 ,  G06F11/00

CPC classification number: H04L47/10 ,  H04L47/20 ,  H04L47/27 ,  H04L47/28

Abstract: A method is described that resets a first count and resets a second count if a first transmission unit is recognized as being within a new measurement time window. The first transmission unit has a size. The method also increments the first count by the first transmission unit size and by the size of each subsequent transmission unit that is received within the new measurement time window after the first transmission unit—so long as the first count does not exceed a maximum allowable value for the first count. The method also checks if a maximum value for the second count is exceeded if it is incremented by a second transmission unit size. The second transmission unit is received within the measurement time window. The check is in response to a determination that the first count would have exceeded the first count maximum allowable valuable if the first count were incremented by the second transmission unit size.

Abstract translation: 描述了如果第一传输单元被识别为在新的测量时间窗内，则复位第一计数并复位第二计数的方法。 第一传输单元具有大小。 该方法还通过第一传输单元大小和在第一传输单元之后的新测量时间窗口内接收的每个后续传输单元的大小来增加第一计数 - 只要第一计数不超过最大允许值 为第一个计数。 该方法还检查是否超过第二个计数的最大值，如果它增加了第二个传输单元大小。 在测量时间窗口内接收第二传输单元。 该检查是响应于确定第一计数将超过第一计数最大允许值，如果第一计数增加第二传输单元大小。

公开(公告)号：US20070292477A1

公开(公告)日：2007-12-20

申请号：US10581710

申请日：2004-12-06

Applicant: Naresh Kumar

Inventor： Naresh Kumar

IPC: A61K31/765 ,  A61K31/787 ,  A61K9/00 ,  A61L15/20 ,  A61M25/00 ,  A61P31/00 ,  C07D207/24 ,  C07D307/26

CPC classification number: C07D307/58 ,  A61K31/341 ,  A61K31/4015 ,  A61K47/59 ,  A61K47/60 ,  C07B2200/11 ,  C07D207/44 ,  C07F7/1804 ,  C08G77/38 ,  C08G77/388 ,  G02B1/043

Abstract: The invention describes antimicrobial silicone oligomers or polymers comprising a silicone oligomer or polymer associated with at least one compound of formula (I). Also described are methods of associating compounds of formula (I) to surfaces and products thereof.

Abstract translation: 本发明描述了抗微生物聚硅氧烷低聚物或包含与至少一种式（I）化合物缔合的聚硅氧烷低聚物或聚合物的聚合物。 还描述了将式（I）化合物与其表面及其产物缔合的方法。

公开(公告)号：US20070106078A1

公开(公告)日：2007-05-10

申请号：US10543517

申请日：2004-01-30

Applicant: Mukesh Sharma ,  Chandra Khanduri ,  Naresh Kumar ,  Yatendra Kumar

Inventor： Mukesh Sharma ,  Chandra Khanduri ,  Naresh Kumar ,  Yatendra Kumar

IPC: C07D211/34

CPC classification number: C07D211/22

Abstract: The invention relates to highly pure fexofenadine and a process for preparing highly pure fexofenadine. The invention also relates to pharmaceutical compositions that include the highly pure fexofenadine and use of said compositions for treating a patient for allergic reactions.

Abstract translation: 本发明涉及高纯度非索非那定和制备高纯度非索非那定的方法。 本发明还涉及包含高纯度非索非那定的药物组合物和所述组合物用于治疗患者过敏反应的用途。